Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 7 Hills, ABL, Affimed, Biomed, Cohbar, Exo, Genpharm, Modex, Morphogenesis, Neoleukin, Nona, Novo Nordisk, Pathos AI, Rhythm.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aiviva, Alnylam, Alpine, Anixa, Apnimed, Atyr, Bridgebio, Candel, Corium, Hanall, Hepion, Immix, Medincell, Milestone, Mink, Mirum, Neurimmune, Novartis, Novo Nordisk, Rain, Redhill, Regeneron, Salubris, Vicore.

Biopharmas raising money in public or private financings, including: Agile, Athersys, Bavarian, Nordic, Cabaletta, Checkpoint, Larkspur, Navidea, Onkure, Oxurion, Smartbax, Syridex, Xbrane.

New hires and promotions in the biopharma industry, including: Bioage, Bioinvent, Calcimedica, Engimmune, Exo, G1, Life, Obsidian, Theriva.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Beta Bionics, Orlucent.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aethlon, Freenome, G Medical, Inari, Lumicell, Oncimmune.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbott, Boston Scientific, Corvia Medical, EBR Systems, Endotronix, Implicity, Medtronic.

Med-tech firms raising money in public or private financings, including: Daxor, Debx Medical.

New hires and promotions in the med-tech industry, including: Angle, Quantim-Si.

The top 10 med-tech stock gainers and losers for the week.